Zoe Alexandra Anaman, MD
Family Practice · Merced
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 10 years
- University of Arkansas College of Medicine, 2016
Offices
1 location · Timothy S Johnston MD PC · 9 clinicians in this group
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Anaman’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A162273 · Current
Licensed to practise in California · since 2019 · expires 2027-05-31 · University of Arkansas for Medical Sciences College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 96.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Original Medicare doctor bills
$37,207
Medicare paid this office $37,207 for 134 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 46 | $6,974 | $96 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 37 | $5,195 | $140 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $4,011 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $2,716 | $97 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 13 | $2,406 | $49 |
See all 13 services
| Return visit (30+ min) | 46 | $6,974 | $96 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 37 | $5,195 | $140 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $4,011 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $2,716 | $97 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 13 | $2,406 | $49 |
| Influenza vaccine, inactivated | 21 | $1,274 | $61 |
| Short return visit (20+ min) | 14 | $1,042 | $65 |
| Hospital discharge day management, 30 minutes or less | 16 | $1,023 | $64 |
| Annual alcohol misuse screening, 5 to 15 minutes | 45 | $941 | $21 |
| Annual depression screening, 5 to 15 minutes | 44 | $920 | $21 |
| Administration of influenza virus vaccine | 25 | $823 | $33 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 19 | $360 | $14 |
| Hemoglobin a1c level | 16 | $267 | $10 |
Who their Medicare patients are
134 Original Medicare patients in 2024. Average age 73 · Under 65 15% · 85 and older 17% · Women 71% · Also on Medicaid 39% · Health risk score 1.61. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 37% · Chronic kidney disease 37% · Coronary heart disease 28% · Heart failure 28% · Depression 22% · Atrial fibrillation 19% · COPD 16% · Stroke 14% · Dementia 10% · Cancer 9%.
The office billed $56,910, Medicare allowed $45,201 and paid $37,207; for 1,394 services of 46 kinds; $3,037 of it was for drugs given in the office and $34,170 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 134 | 1,394 | 73 | 1.61 | $56,910 | $37,207 |
| 2023 | 192 | 1,061 | 73 | 1.71 | $69,670 | $42,526 |
| 2022 | 206 | 1,163 | 74 | 1.88 | $90,855 | $52,547 |
| 2021 | 197 | 744 | 73 | 1.75 | $96,940 | $54,195 |
| 2020 | 91 | 322 | 73 | 2.60 | $38,265 | $21,588 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $7,741 | $65 |
| Return visit (30+ min) | 62 | $7,517 | $78 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 45 | $6,075 | $135 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,070 | $106 |
| Hospital discharge day management, 30 minutes or less | 41 | $2,915 | $66 |
| Short return visit (20+ min) | 28 | $2,039 | $60 |
| New patient visit (45+ min) | 14 | $1,515 | $108 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 20 | $1,505 | $75 |
| Annual depression screening, 5 to 15 minutes | 58 | $1,140 | $20 |
| Annual alcohol misuse screening, 5 to 15 minutes | 47 | $924 | $20 |
| Administration of influenza virus vaccine | 22 | $739 | $32 |
| Hemoglobin a1c level | 15 | $219 | $10 |
2022: 14 services
| Return visit (30+ min) | 76 | $11,125 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 63 | $9,319 | $55 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 55 | $7,442 | $135 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 46 | $4,988 | $106 |
| Hospital discharge day management, 30 minutes or less | 52 | $3,074 | $58 |
| New patient visit (45+ min) | 17 | $1,541 | $91 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 18 | $1,265 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,187 | $74 |
| Short return visit (20+ min) | 21 | $1,103 | $50 |
| Annual depression screening, 5 to 15 minutes | 57 | $1,101 | $19 |
| Administration of influenza virus vaccine | 20 | $614 | $31 |
| Annual alcohol misuse screening, 5 to 15 minutes | 22 | $429 | $19 |
| Administration of pneumococcal vaccine | 12 | $367 | $31 |
| Hemoglobin a1c level | 15 | $240 | $10 |
2021: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 78 | $12,239 | $58 |
| Return visit (30+ min) | 64 | $10,011 | $88 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 62 | $7,256 | $108 |
| Hospital discharge day management, more than 30 minutes | 43 | $4,435 | $87 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 27 | $3,625 | $134 |
| New patient visit (45+ min) | 30 | $3,532 | $118 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,444 | $153 |
| Short return visit (20+ min) | 25 | $1,946 | $65 |
| Hospital discharge day management, 30 minutes or less | 21 | $1,239 | $59 |
| Influenza vaccine, inactivated | 13 | $774 | $60 |
| Annual depression screening, 5 to 15 minutes | 32 | $629 | $20 |
| Hemoglobin a1c level | 21 | $291 | $10 |
| Administration of influenza virus vaccine | 15 | $267 | $18 |
2020: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $5,451 | $60 |
| Return visit (30+ min) | 28 | $3,861 | $84 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,385 | $114 |
| Hospital discharge day management, more than 30 minutes | 25 | $2,316 | $86 |
| Influenza vaccine, inactivated | 11 | $655 | $60 |
| Annual depression screening, 5 to 15 minutes | 14 | $269 | $19 |
| Administration of influenza virus vaccine | 12 | $212 | $18 |
| Hemoglobin a1c level | 12 | $165 | $10 |
Medicaid work
$64,938 in 2024
Medicaid paid $64,938 for 761 billed services this clinician did in 2024, up to 80 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 306 | $58,957 |
| Developmental screening | 20 | $2,275 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 38 | $1,187 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 13 | $1,014 |
| Screening performed and negative | 14 | $549 |
| Pure tone audiometry (threshold); air only | 14 | $434 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 13 | $287 |
| Return visit (30+ min) | 172 | $90 |
| Bilateral quantitative screening test of visual acuity | 13 | $81 |
| HEMOGLOBIN | 39 | $64 |
| Short return visit (20+ min) | 106 | $0 |
| Other evaluation and management service | 13 | $0 |
| 2024 | 761 | 12 | 80 | $64,938 |
| 2023 | 824 | 12 | 39 | $46,912 |
| 2022 | 1,198 | 13 | 51 | $64,594 |
| 2021 | 1,692 | 18 | 70 | $96,358 |
| 2020 | 830 | 8 | 169 | $101,700 |
| 2019 | 256 | 2 | 94 | $40,135 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 166 | $31,495 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 101 | $9,140 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 63 | $1,494 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 16 | $1,110 |
| Initial hospital or birthing center care, per day, for evaluation and management of normal newborn infant | 14 | $1,055 |
| Return visit (30+ min) | 248 | $885 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 23 | $482 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 72 | $455 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 13 | $362 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 12 | $338 |
| Short return visit (20+ min) | 79 | $68 |
| HEMOGLOBIN | 17 | $29 |
2022
| Clinic visit/encounter, all-inclusive | 169 | $31,237 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 177 | $16,057 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 217 | $6,937 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 72 | $2,459 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 41 | $2,308 |
| Developmental screening | 14 | $1,677 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 17 | $1,219 |
| Return visit (30+ min) | 302 | $1,021 |
| Initial hospital or birthing center care, per day, for evaluation and management of normal newborn infant | 14 | $901 |
| Short return visit (20+ min) | 130 | $442 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 12 | $220 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 17 | $115 |
2021
| Clinic visit/encounter, all-inclusive | 428 | $78,418 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 124 | $3,481 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 55 | $2,964 |
| Short return visit (20+ min) | 334 | $2,210 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 19 | $1,724 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 46 | $1,570 |
| Return visit (30+ min) | 357 | $1,392 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 16 | $1,110 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 44 | $951 |
| Initial hospital or birthing center care, per day, for evaluation and management of normal newborn infant | 12 | $901 |
| Subsequent hospital care, per day, for evaluation and management of normal newborn | 19 | $742 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 51 | $361 |
2020
| Clinic visit/encounter, all-inclusive | 531 | $95,262 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 17 | $1,542 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 17 | $1,240 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 21 | $1,145 |
| Short return visit (20+ min) | 97 | $945 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 38 | $714 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 30 | $586 |
| Return visit (30+ min) | 79 | $266 |
2019
| Clinic visit/encounter, all-inclusive | 218 | $39,246 |
| Short return visit (20+ min) | 38 | $889 |
Drugs they prescribed that Part D paid
$296,761
Pharmacies billed $296,761 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (19 of 1,738) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
1,485 generic and 241 brand-name prescriptions · $296,761 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Otezla | 13 | $74,063 | $5,697 |
| Ozempic | 46 | $48,732 | $1,059 |
| Rybelsus | 23 | $36,358 | $1,581 |
| Jardiance | 21 | $22,396 | $1,066 |
| Mounjaro | 13 | $20,606 | $1,585 |
See all 39 drugs
| Otezla | 13 | $74,063 | $5,697 |
| Ozempic | 46 | $48,732 | $1,059 |
| Rybelsus | 23 | $36,358 | $1,581 |
| Jardiance | 21 | $22,396 | $1,066 |
| Mounjaro | 13 | $20,606 | $1,585 |
| Atorvastatin | 181 | $2,255 | $12 |
| Albuterol Sulfate Hfa | 44 | $1,122 | $26 |
| Azelastine | 16 | $1,101 | $69 |
| Omeprazole | 59 | $934 | $16 |
| Gabapentin | 49 | $900 | $18 |
| Losartan | 81 | $821 | $10 |
| Lisinopril | 71 | $780 | $11 |
| Levothyroxine | 60 | $642 | $11 |
| Sertraline | 39 | $579 | $15 |
| Ibuprofen | 35 | $546 | $16 |
| Metformin | 64 | $537 | $8 |
| Pravastatin | 24 | $483 | $20 |
| Oxybutynin Chloride Er | 13 | $476 | $37 |
| Mirtazapine | 23 | $452 | $20 |
| Clotrimazole | 12 | $426 | $35 |
| Rosuvastatin | 11 | $375 | $34 |
| Escitalopram | 29 | $357 | $12 |
| Fenofibrate | 15 | $340 | $23 |
| Montelukast | 26 | $335 | $13 |
| Hydrochlorothiazide | 52 | $322 | $6 |
| Carvedilol | 34 | $294 | $9 |
| Fluticasone Propionate | 14 | $289 | $21 |
| Amlodipine Besylate | 51 | $281 | $6 |
| Simvastatin | 34 | $280 | $8 |
| Metformin Hcl Er | 21 | $245 | $12 |
| Meclizine | 14 | $244 | $17 |
| Losartan-Hydrochlorothiazide | 23 | $241 | $10 |
| Glipizide | 12 | $187 | $16 |
| Pioglitazone | 11 | $185 | $17 |
| Quetiapine | 16 | $163 | $10 |
| Bupropion Xl | 11 | $130 | $12 |
| Lisinopril-Hydrochlorothiazide | 16 | $103 | $6 |
| Alendronate | 11 | $50 | $5 |
| Benazepril | 14 | $38 | $3 |
Year by year
| 2024 | 1,738 | 168 | 1% (19) | 14% | $296,761 |
| 2023 | 2,017 | 191 | 1% (17) | None | $259,844 |
| 2022 | 1,819 | 196 | 2% (30) | 12% | $189,127 |
| 2021 | 1,549 | 180 | 2% (31) | 17% | $164,438 |
| 2020 | 946 | 138 | 5% (51) | 15% | $84,222 |
| 2019 | 520 | 88 | 4% (23) | None | $46,935 |
| 2018 | 403 | 64 | None | None | $24,472 |
| 2017 | 280 | 56 | 4% (11) | 19% | $9,359 |
| 2016 | 24 | 14 | None | None | $819 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 45 drugs
| Rybelsus | 31 | $45,411 | $1,465 |
| Jardiance | 23 | $25,922 | $1,127 |
| Ozempic | 17 | $19,915 | $1,171 |
| Trulicity | 14 | $13,910 | $994 |
| Lantus Solostar | 17 | $8,358 | $492 |
| Atorvastatin | 198 | $3,538 | $18 |
| Diclofenac | 31 | $1,762 | $57 |
| Losartan | 84 | $1,623 | $19 |
| Albuterol Sulfate Hfa | 40 | $1,449 | $36 |
| Lisinopril | 119 | $1,269 | $11 |
| Gabapentin | 59 | $1,239 | $21 |
| Levothyroxine | 74 | $1,196 | $16 |
| Metformin | 95 | $1,102 | $12 |
| Lidocaine | 12 | $1,068 | $89 |
| Omeprazole | 61 | $906 | $15 |
| Carvedilol | 56 | $728 | $13 |
| Sertraline | 35 | $681 | $19 |
| Azelastine | 12 | $671 | $56 |
| Fenofibrate | 20 | $665 | $33 |
| Amlodipine Besylate | 67 | $612 | $9 |
| Escitalopram | 22 | $524 | $24 |
| Losartan-Hydrochlorothiazide | 30 | $479 | $16 |
| Simvastatin | 43 | $420 | $10 |
| Pravastatin | 25 | $416 | $17 |
| Ibuprofen | 32 | $380 | $12 |
| Mirtazapine | 20 | $368 | $18 |
| Glipizide | 16 | $319 | $20 |
| Metformin Hcl Er | 22 | $282 | $13 |
| Metoprolol | 16 | $281 | $18 |
| Meclizine | 15 | $258 | $17 |
| Fluticasone Propionate | 15 | $233 | $16 |
| Hydrochlorothiazide | 66 | $227 | $3 |
| Clopidogrel | 15 | $215 | $14 |
| Benazepril | 14 | $196 | $14 |
| Baclofen | 12 | $196 | $16 |
| Trazodone | 12 | $164 | $14 |
| Alendronate | 12 | $162 | $13 |
| Famotidine | 16 | $149 | $9 |
| Glipizide Er | 13 | $147 | $11 |
| Meloxicam | 12 | $137 | $11 |
| Quetiapine | 16 | $124 | $8 |
| Lisinopril-Hydrochlorothiazide | 12 | $108 | $9 |
| Montelukast | 12 | $106 | $9 |
| Metoprolol | 11 | $99 | $9 |
| Tramadol | 11 | $23 | $2 |
2022: 40 drugs
| Rybelsus | 23 | $30,414 | $1,322 |
| Lantus Solostar | 16 | $9,875 | $617 |
| Trelegy Ellipta | 12 | $8,521 | $710 |
| Albuterol Sulfate Hfa | 41 | $2,191 | $53 |
| Atorvastatin | 167 | $2,185 | $13 |
| Celecoxib | 13 | $1,621 | $125 |
| Levothyroxine | 67 | $1,259 | $19 |
| Quetiapine | 13 | $908 | $70 |
| Lisinopril | 110 | $907 | $8 |
| Omeprazole | 64 | $870 | $14 |
| Metformin | 104 | $821 | $8 |
| Losartan | 44 | $714 | $16 |
| Gabapentin | 42 | $691 | $16 |
| Estradiol | 15 | $553 | $37 |
| Carvedilol | 55 | $539 | $10 |
| Chlorthalidone | 13 | $505 | $39 |
| Fenofibrate | 16 | $448 | $28 |
| Pravastatin | 24 | $432 | $18 |
| Losartan-Hydrochlorothiazide | 24 | $430 | $18 |
| Amlodipine Besylate | 66 | $417 | $6 |
| Ibuprofen | 29 | $406 | $14 |
| Meclizine | 17 | $370 | $22 |
| Fluoxetine | 28 | $363 | $13 |
| Enalapril Maleate | 12 | $338 | $28 |
| Simvastatin | 39 | $301 | $8 |
| Sertraline | 31 | $285 | $9 |
| Hydrocodone-Acetaminophen | 13 | $258 | $20 |
| Alendronate | 23 | $223 | $10 |
| Benazepril | 17 | $193 | $11 |
| Montelukast | 14 | $190 | $14 |
| Hydrochlorothiazide | 46 | $176 | $4 |
| Escitalopram | 11 | $157 | $14 |
| Clopidogrel | 22 | $153 | $7 |
| Hydralazine | 11 | $139 | $13 |
| Pantoprazole | 11 | $138 | $13 |
| Famotidine | 18 | $117 | $6 |
| Tramadol | 17 | $106 | $6 |
| Venlafaxine Hcl Er | 12 | $90 | $7 |
| Metoprolol | 16 | $70 | $4 |
| Furosemide | 11 | $66 | $6 |
2021: 38 drugs
| Lantus Solostar | 28 | $17,307 | $618 |
| Jardiance | 11 | $13,422 | $1,220 |
| Humalog Kwikpen U-100 | 12 | $8,508 | $709 |
| Eliquis | 11 | $7,978 | $725 |
| Breo Ellipta | 13 | $5,953 | $458 |
| Albuterol Sulfate Hfa | 44 | $2,250 | $51 |
| Lactulose | 14 | $1,651 | $118 |
| Atorvastatin | 130 | $1,624 | $12 |
| Levothyroxine | 62 | $1,207 | $19 |
| Gabapentin | 44 | $904 | $21 |
| Memantine | 13 | $881 | $68 |
| Celecoxib | 12 | $861 | $72 |
| Omeprazole | 66 | $834 | $13 |
| Ultra-Fine Mini Pen Needle | 11 | $578 | $53 |
| Metformin | 67 | $562 | $8 |
| Lisinopril | 82 | $557 | $7 |
| Hydrocodone-Acetaminophen | 22 | $522 | $24 |
| Duloxetine | 13 | $521 | $40 |
| Losartan | 41 | $471 | $11 |
| Chlorthalidone | 15 | $466 | $31 |
| Fluticasone Propionate | 23 | $412 | $18 |
| Carvedilol | 37 | $373 | $10 |
| Ibuprofen | 24 | $370 | $15 |
| Amlodipine Besylate | 63 | $369 | $6 |
| Montelukast | 20 | $357 | $18 |
| Fluoxetine | 16 | $331 | $21 |
| Naproxen | 15 | $269 | $18 |
| Pantoprazole | 12 | $242 | $20 |
| Losartan-Hydrochlorothiazide | 17 | $238 | $14 |
| Benazepril | 22 | $231 | $11 |
| Pioglitazone | 11 | $220 | $20 |
| Fenofibrate | 14 | $171 | $12 |
| Hydrochlorothiazide | 41 | $148 | $4 |
| Metformin Hcl Er | 13 | $146 | $11 |
| Meclizine | 12 | $120 | $10 |
| Simvastatin | 29 | $116 | $4 |
| Metoprolol | 11 | $99 | $9 |
| Furosemide | 11 | $74 | $7 |
2020: 20 drugs
| Lantus Solostar | 15 | $7,423 | $495 |
| Atorvastatin | 78 | $952 | $12 |
| Albuterol Sulfate Hfa | 12 | $561 | $47 |
| Hydrocodone-Acetaminophen | 32 | $544 | $17 |
| Omeprazole | 50 | $533 | $11 |
| Gabapentin | 37 | $437 | $12 |
| Lisinopril | 66 | $402 | $6 |
| Ibuprofen | 22 | $345 | $16 |
| Levothyroxine | 12 | $294 | $24 |
| Metformin | 45 | $274 | $6 |
| Carvedilol | 34 | $268 | $8 |
| Fluticasone Propionate | 15 | $267 | $18 |
| Hydrochlorothiazide | 23 | $174 | $8 |
| Amlodipine Besylate | 42 | $172 | $4 |
| Losartan | 16 | $131 | $8 |
| Metformin Hcl Er | 11 | $97 | $9 |
| Simvastatin | 14 | $84 | $6 |
| Glipizide | 17 | $77 | $5 |
| Tramadol | 12 | $68 | $6 |
| Naproxen | 12 | $65 | $5 |
2019: 11 drugs
| Levothyroxine | 30 | $426 | $14 |
| Metoprolol | 12 | $338 | $28 |
| Atorvastatin | 29 | $333 | $11 |
| Gabapentin | 11 | $322 | $29 |
| Hydrocodone-Acetaminophen | 17 | $189 | $11 |
| Venlafaxine Hcl Er | 11 | $188 | $17 |
| Furosemide | 24 | $113 | $5 |
| Lisinopril | 20 | $108 | $5 |
| Amlodipine Besylate | 15 | $89 | $6 |
| Clonazepam | 12 | $33 | $3 |
| Meloxicam | 14 | $23 | $2 |
2018: 7 drugs
| Gabapentin | 23 | $404 | $18 |
| Levothyroxine | 25 | $332 | $13 |
| Metoprolol | 14 | $249 | $18 |
| Atorvastatin | 14 | $232 | $17 |
| Metformin | 24 | $127 | $5 |
| Furosemide | 29 | $126 | $4 |
| Lisinopril | 21 | $117 | $6 |
2017: 4 drugs
| Gabapentin | 15 | $155 | $10 |
| Levothyroxine | 11 | $92 | $8 |
| Furosemide | 14 | $49 | $3 |
| Lisinopril | 12 | $41 | $3 |
Money from drug and device companies
$198 in 2025
| 2025 | 6 | 9 | None | $198 |
| 2024 | 11 | 22 | None | $451 |
| 2023 | 15 | 28 | None | $516 |
| 2022 | 8 | 25 | None | $510 |
| 2021 | 11 | 22 | None | $457 |
| 2020 | 7 | 10 | None | $165 |
| 2019 | 4 | 4 | None | $159 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Qulipta | $48 | 2 payments
|
| Amgen | Otezla | $38 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $34 | 2 payments
|
| Novo Nordisk | Ozempic | $33 | 1 payment
|
| Axsome Therapeutics | Auvelity | $29 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Breztri | $16 | 1 payment
|
See all 9 published payments
| Amgen | Meals · 2025-08-14 | Otezla | $16 |
| Amgen | Meals · 2025-04-29 | Otezla | $22 |
| Abbvie | Meals · 2025-04-04 | Vraylar | $19 |
| Novo Nordisk | Meals · 2025-04-03 | Ozempic | $33 |
| Abbvie | Meals · 2025-03-12 | Qulipta | $30 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-06 | Breztri | $16 |
| Axsome Therapeutics | Meals · 2025-03-06 | Auvelity | $29 |
| GlaxoSmithKline | Meals · 2025-02-12 | Trelegy Ellipta | $18 |
| GlaxoSmithKline | Meals · 2025-01-21 | Shingrix | $16 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $451
| GlaxoSmithKline | Shingrix | $143 | 9 payments
|
| Axsome Therapeutics | Auvelity | $110 | 3 payments
|
| Smith+Nephew | Regranex | $36 | 1 payment
|
| Novo Nordisk | Rybelsus | $36 | 2 payments
|
| Merck Sharp & Dohme | Delstrigo | $25 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 3 | $25 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $19 | 1 payment
|
| Pfizer | Nurtec Odt | $15 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $14 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $14 | 1 payment
|
| Amgen | Otezla | $13 | 1 payment
|
2023: $516
| AbbVie | Vraylar | $98 | 4 payments
|
| GlaxoSmithKline | Shingrix | $64 | 4 payments
|
| Pfizer | Comirnaty | $53 | 3 payments
|
| Novo Nordisk | Rybelsus | $50 | 3 payments
|
| Dexcom | Dexcom G6 Transmitter | $49 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $41 | 3 payments
|
| Cranial Technologies | Doc Band | $22 | 1 payment
|
| Kci USA | Activ.A.C. | $21 | 1 payment
|
| Iti | Caplyta | $21 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $19 | 1 payment
|
| Xeris Pharmaceuticals | Gvoke Hypopen | $19 | 1 payment
|
| Sanofi Pasteur | Menquadfi | $17 | 1 payment
|
| Lilly USA | Jardiance | $15 | 1 payment
|
| Merck Sharp & Dohme | Rotateq | $14 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Tradjenta | $13 | 1 payment
|
2022: $510
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $133 | 8 payments
|
| Novo Nordisk | Rybelsus | $121 | 3 payments
|
| Cranial Technologies | Doc Band | $78 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $44 | 3 payments
|
| Abbvie | Ubrelvy | $39 | 2 payments
|
| GlaxoSmithKline | Shingrix | $39 | 2 payments
|
| Merck Sharp & Dohme | Belsomra | $37 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $18 | 1 payment
|
2021: $457
| Novo Nordisk | Ozempic | $166 | 4 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $83 | 5 payments
|
| Janssen Pharmaceuticals | Xarelto | $44 | 2 payments
|
| Dexcom | Dexcom G6 Transmitter | $30 | 2 payments
|
| Merck Sharp & Dohme | Verquvo | $30 | 2 payments
|
| Pfizer | Prevnar 13 | $29 | 2 payments
|
| Lilly USA | Trulicity | $22 | 1 payment
|
| GlaxoSmithKline | Pediarix | $17 | 1 payment
|
| Hologic | Aptima | $13 | 1 payment
|
| Cranial Technologies | Doc Band | $12 | 1 payment
|
| Organon | Nexplanon | $10 | 1 payment
|
2020: $165
| Amgen | Aimovig | $42 | 2 payments
|
| Pfizer | Cologuard | $27 | 2 payments
|
| Merck Sharp & Dohme | Nexplanon | $23 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $22 | 1 payment
|
| Gilead Sciences | None | $21 | 1 payment
|
| Hologic | Thinprep | $19 | 1 payment
|
| Lilly USA | Trulicity | $12 | 1 payment
|
2019: $159
| Pfizer | Cologuard | $102 | 1 payment
|
| GlaxoSmithKline | Bexsero | $21 | 1 payment
|
| Merck Sharp & Dohme | Januvia | $20 | 1 payment
|
| Amgen | Aimovig | $16 | 1 payment
|
Professional record
- NPI
- 1326400532
- Licence
- CA A162273California A162273: Current · expires 2027-05-31
- Trained
- University of Arkansas College of Medicine, 2016 · 10 years ago
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 3349 G St Ste F, Merced, CA, 95340
- NPI first listed
- 2016-03-26
- NPI last updated
- 2025-07-28
- NPI record certified
- 2025-07-28
This is when the NPI record was last certified, not a medical board exam.